Skip to main content
Amanda Schafenacker, MD, Pediatrics, Orange, CA, Children’s Health Orange County (CHOC)

AmandaMarieSchafenackerMD

Pediatrics Orange, CA

Hospitalist

Pediatric Hospitalist

Dr. Schafenacker is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Schafenacker's full profile

Already have an account?

Education & Training

  • University of California (Irvine)/Children's Hospital of Orange County
    University of California (Irvine)/Children's Hospital of Orange CountyFellowship, Pediatric Hospital Medicine, 2021 - 2023
  • University of California (Irvine)/Children's Hospital of Orange County
    University of California (Irvine)/Children's Hospital of Orange CountyChief Residency, Pediatrics, 2019 - 2020
  • University of California (Irvine)/Children's Hospital of Orange County
    University of California (Irvine)/Children's Hospital of Orange CountyResidency, Pediatrics, 2016 - 2019
  • University of California, Irvine, School of Medicine
    University of California, Irvine, School of MedicineClass of 2016
  • University of California at Los Angeles
    University of California at Los AngelesBS, Molecular, Cell, and Developmental Biology, Cum Laude, 2008 - 2012

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2017 - 2025
  • American Board of Pediatrics Pediatrics

Publications & Presentations

PubMed

Journal Articles

  • Hematuria in a 7-year-old Internationally Adopted Male  
    Amanda Schafenacker, Jasjit Singh, The Pediatric Infectious Disease Journal, 10/2020

Abstracts/Posters

  • No Device, But Still a Problem: A Five Year Review of Healthcare Associated Bloodstream and Urinary Tract Infections in a Children’s Hospital
    Amanda Schafenacker; Wendi Gornick; Beth Huff; Jasjit Singh, ID Week, Washington, DC, 10/22/2022
  • Development of selective therapy of childhood ALL and Ewing's sarcoma using targeted-hybrid polymerized liposomal nanoparticles (HPLN)
    Kang K, Shahbazian V, Schafenacker A, Nagy J, Triche T., American Association of Cancer Research, San Diego, 4/2014

Professional Memberships

Hospital Affiliations